FeesSafety
Pluang+

Nexentis subsidiary MitoCareX advances drug discovery with AI-selected molecules for lab testing.

Market News
17 Nov 2026, 15:03 WIB
Globe News Wire
View Source
Bullish
Nexentis subsidiary MitoCareX advances drug discovery with AI-selected molecules for lab testing.

Nexentis Technologies' subsidiary MitoCareX Bio has selected and ordered molecules for planned in-vitro testing after further AI-driven computational screening. This step follows initial promising computational predictions made with AI partner Boltz and aims to experimentally evaluate these molecules to decide on further development. The molecules have not yet been tested, and their biological activity remains unconfirmed. This initiative combines biology, chemistry, and AI to identify potential drug candidates, but further validation is needed to confirm their suitability.

Nexentis Technologies' MitoCareX advances toward in-vitro testing after AI-driven molecule screening, providing context for health sector activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Nov 17, 2026 20:04 WIB: out of 150 priced US health-sector stocks, 49 rose and 91 fell. Notable movers include SLS (SELLAS Life Sciences Group Inc.) at USD 8.00 with a 1-day change of +7.10% and Pluang order activity of 4% Sell / 96% Buy, and SANA (Sana Biotechnology Inc) at USD 2.00 with a 1-day change of +6.38% and 0% Sell / 100% Buy order activity.

More News

Adagene and City of Hope launch Phase 1 trial for new colorectal cancer combo therapy.

Adagene and City of Hope launch Phase 1 trial for new colorectal cancer combo therapy.

Adagene Inc. and City of Hope have started a Phase 1 clinical trial testing a new combination therapy for metastatic colorectal cancer patients resistant to standard treatments. The trial evaluates two experimental drugs, ivonescimab and muzastotug (...

Others
Bullish
58 minutes ago
Provident Bank appoints three leaders to boost commercial banking growth and services.

Provident Bank appoints three leaders to boost commercial banking growth and services.

Provident Bank announced three key leadership appointments to strengthen its Commercial Banking division. Edward Galan will lead Middle Market Lending, Dawn Scocco will manage portfolio and credit risk, and John Maio will head Treasury Management Ser...

Market News
Bullish
58 minutes ago
RoyaLand launches its first mobile game Palazzo Chronicles: Match 3 on Google Play.

RoyaLand launches its first mobile game Palazzo Chronicles: Match 3 on Google Play.

RoyaLand Company Ltd. has released its first mobile game, Palazzo Chronicles: Match 3, on the Google Play Store. The free-to-play match-3 puzzle game features over 270 levels where players restore a royal palace set in Risorgimento Italy. This launch...

Others
Bullish
58 minutes ago
Atiq Khan joins Dune as Director of Engineering to lead real-time onchain market data development.

Atiq Khan joins Dune as Director of Engineering to lead real-time onchain market data development.

Atiq Khan, with over 25 years in financial technology including roles at Goldman Sachs and Coinbase, has joined Dune as Director of Engineering. He will lead the engineering efforts behind Dune Market Data Feeds, which provide real-time trade and liq...

Others
Bullish
58 minutes ago
BlackRock increases voting rights in ICG PLC to 5.16% as of November 13, 2026

BlackRock increases voting rights in ICG PLC to 5.16% as of November 13, 2026

BlackRock, Inc. has increased its total voting rights in ICG PLC to 5.16% as of November 13, 2026, up from 5.17% previously reported. This includes 5.08% voting rights attached to shares and 0.08% through financial instruments. The notification was o...

Market News
Neutral
58 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App